Current Neuro-Oncology
Volume
26 Number 25
10 November 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 25, 10 November
*Chiche D, Taillandier L, Blonski M, Planel S, Obara T, Anxionnat
R, Rech F.
DTI analysis of the
peritumoral zone of diffuse low-grade gliomas in progressing
patients.
World Neurosurg. 2024 Nov
1:S1878-8750(24)01811-4? doi: 10.1016/j.wneu.2024.10.111? PMID:
39489335. Observational study˰
ˍ
*Gao L, Yuan T, Liu Y, Yang X, Li Y, Quan G.
Prognostic
nomogram model based on quantitative metrics of subregions
surrounding residual cavity in glioblastoma patients.
J
Cancer Res Clin Oncol. 2024 Nov 1;150(11):483. doi:
10.1007/s00432-024-06008-6. PMID:
39487262. Observational study. ˍ
Khalafallah AM, Shah KH, Knott MV, Berke CN, Shah AH, Komotar RJ,
Ivan ME.
Evaluating laser interstitial
thermal therapy for newly diagnosed, deep-seated, large-volume
glioblastoma: survival and outcome analysis.
Neurosurg
Focus. 2024 Nov 1;57(5):E3. doi:
10.3171/2024.8.FOCUS24457. PMID:
39486051. Observational study. ˍ
Mehta NH, Patel RV, Gupta S, Arora H, Nawabi NL, Karanth R, Sadler
S, Medeiros L, Jha R, Chavarro VS, Bernstock JD, Smith TR, Arnaout
O.
Cerebellopontine Angle Meningiomas:
A Multi-Institutional Cohort Study.
Neurosurgery.
2024 Nov 1. doi:
10.1227/neu.0000000000003258. PMID:
39485023. Case report˰
ˍ
Peña Pino I, Bartek J, Ben-Haim S, Chen CC.
Patient-reported outcome and
preference after craniotomy and laser interstitial thermal therapy
ablation: a pilot study.
Neurosurg
Focus. 2024 Nov 1;57(5):E7. doi:
10.3171/2024.8.FOCUS24442. PMID:
39486062. Observational study. ˍ
Wilhelmy B, Serra R, Chen C, Mishra M, Rodrigues D, Badjatia N,
Motta M, Ksendzovsky A, Woodworth GF.
An
analysis of functional outcomes following laser interstitial
thermal therapy for recurrent high-grade glioma.
Neurosurg
Focus. 2024 Nov 1;57(5):E4. doi:
10.3171/2024.8.FOCUS24460. PMID:
39486067. Observational study. ˍ
Basso J, Matos AM, Ghavami S, Fortuna A, Vitorino R, Vitorino C.
Are we better together? Addressing a
combined treatment of pitavastatin and temozolomide for brain
cancer.
Eur
J Pharmacol. 2024 Nov 2;985:177087. doi:
10.1016/j.ejphar.2024.177087. PMID:
39491742. Laboratory investigation. ˍ
Fujimoto Y, Fujita Y, Tanaka K, Nagashima H, Yamanishi S, Ikeuchi
Y, Iwahashi H, Sanada S, Muragaki Y, Sasayama T.
Clinical
Benefits of Photodynamic Therapy Using Talaporfin Sodium in
Patients With Isocitrate Dehydrogenase-Wildtype Diagnosed
Glioblastoma: A Retrospective Study of 100 Cases.
Neurosurgery.
2024 Nov 4. doi:
10.1227/neu.0000000000003247. PMID:
39495040. Observational study˰
ˍ
*Hu X, Zhang G, Xie R, Wang Y, Zhu Y, Ding H.
Contrast-enhanced
ultrasound can differentiate the level of glioma infiltration and
correlate it with biological behavior: a study based on local
pathology.
J
Ultrasound. 2024 Nov 4. doi:
10.1007/s40477-024-00961-1. PMID:
39489864. Observational study˰
ˍ
Karschnia P, Young JS, Youssef GC, Dono A, Häni L, Sciortino
T, Bruno F, Juenger ST, Teske N, Dietrich J, Weller M, Vogelbaum
MA, van den Bent M, Beck J, Thon N, Gerritsen JKW, Hervey-Jumper
S, Cahill DP, Chang SM, Rudà R, Bello L, Schnell O,
Esquenazi Y, Ruge MI, Grau SJ, Huang RY, Wen PY, Berger MS,
Molinaro AM, Tonn JC; RANO resect group.
Development
and validation of a clinical risk model for postoperative outcome
in newly diagnosed glioblastoma: a report of the RANO resect
group.
Neuro
Oncol. 2024 Nov 4:noae231. doi:
10.1093/neuonc/noae231. PMID:
39492786. Observational study. ˍ
Wang M, Liu G, Liang Y, Lyu Z, Tang Z, Tan F, Wei R.
Clinical
results of helical tomotherapy for high-grade gliomas.
Int
J Radiat Biol. 2024 Nov 4:1-13. doi:
10.1080/09553002.2024.2418500. PMID:
39495095. Observational study˰
ˍ
Dinapoli L, Caliandro M, Chiesa S, Marconi E, Capocchiano ND,
Mazzarella C, Bartoli FB, Bracci S, Balducci M, Chieffo DPR,
Fiorentino A, Valentini V, Tagliaferri L, Gambacorta MA, Dinapoli
N.
Resilience and spiritual well-being
as resources for coping with radiotherapy and surviving in
patients with glioblastoma.
Palliat
Support Care. 2024 Nov 5:1-9. doi:
10.1017/S1478951524001111. PMID:
39497355. Observational study. ˍ
*Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA.
Why
are Higher CD34+ Cell Doses Associated with Improved Outcomes
among Pediatric Patients Undergoing Autologous Hematopoietic Stem
Cell Transplant for Central Nervous System Tumors - But Not for
High-Risk Neuroblastoma?
Pediatr
Hematol Oncol. 2024 Nov 5:1-5. doi:
10.1080/08880018.2024.2420924. PMID:
39501613. Observational study˰
ˍ
Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain
MA, Stopka S, Meredith DM, Santagata S, Murphy MM, Arnaout O, Bi
WL, Chiocca EA, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen PY,
Agar NYR, Lee JW.
Pilot Trial of
Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed
High-grade Glioma.
Clin
Cancer Res. 2024 Nov 5:OF1-OF9. doi:
10.1158/1078-0432.CCR-24-1849. PMID:
39499201. Interventional study. ˍ
REFERS
TO:
Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E,
Hossain MA, Stopka S, Santagata S, Murphy MM, Arnaout O, Bi WL,
Antonio Chiocca E, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen
PY, Agar NYR, Lee JW.
Pilot
trial of perampanel on peritumoral hyperexcitability and clinical
outcomes in newly diagnosed high-grade glioma.
medRxiv
[Preprint].
2024 Apr 18:2024.04.11.24305666. doi:
10.1101/2024.04.11.24305666. PMID:
38645003. Interventional study. ˍ
Kan A, Marokakis S, Ward JH, Kim S, Gabriel M, Durkan AM.
Long-term renal outcomes of children
with cancers treated with platinum-based chemotherapy: A
retrospective chart analysis.
Pediatr
Blood Cancer. 2024 Nov 6:e31404. doi:
10.1002/pbc.31404. PMID:
39503057. Observational study˰
ˍ
Landry AP, Wang JZ, Patil V, Gui C, Yasin M, Patel Z, Yakubov R,
Kaloti R, Habibi P, Wilson M, Ajisebutu A, Ellenbogen Y, Wei Q,
Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Virtanen P,
Burket N, Blackwell M, Koenig J, Alfonso A, Davis J, Zaazoue MA,
Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE,
Chotai S, Chambless LB, Mansouri A, Ehret F, Capper D, Tsang DS,
Aldape K, Gao A; International Consortium on Meningiomas (ICOM);
Nassiri F, Zadeh G.
Validation and
next-generation update of a DNA methylation-based recurrence
predictor for meningioma: a multicenter prospective study.
Neuro
Oncol. 2024 Nov 6:noae236. doi:
10.1093/neuonc/noae236. PMID:
39503370. Observational study. ˍ
Mencia Diez FB, Egurrola Izquierdo M, Garcia Hontoria P.
A
Diagnosis of Pulmonary
Metastases of Benign Meningioma Using Radial Endobronchial
Ultrasound.
Open
Respir Arch. 2024 Sep 17;7(1):100364. doi:
10.1016/j.opresp.2024.100364. PMID:
39493969. Case report. ˍ
*Yi Y, Che W, Xu P, Mao C, Li Z, Wang Q, Lyu J, Wang X.
Conversion of glioma cells into
neuron-like cells by small molecules.
iScience.
2024 Oct 2;27(11):111091. doi:
10.1016/j.isci.2024.111091. PMID:
39483145. Laboratory investigation. ˍ
Götz L, Ansafi T, Gerken M, Klinkhammer-Schalke M, Fischl A,
Riemenschneider MJ, Proescholdt M, Bumes E, Kölbl O, Schmidt
NO, Linker R, Hau P, Haedenkamp TM.
Effect
of antibiotic drug use on outcome and therapy-related toxicity in
patients with glioblastoma-A retrospective cohort
study.
Neurooncol
Adv. 2024 Oct 4;6(1):vdae170. doi:
10.1093/noajnl/vdae170. PMID:
39493414. Observational study. ˍ
Luo Y, Gadd ME, Qie Y, Otamendi-Lopez A, Sanchez-Garavito JE,
Brooks MM, Ulloa Navas MJ, Hundal T, Li S, Jones VK, Lou Y, Patel
T, Dronca R, Kharfan-Dabaja MA, Dong H, Quinones-Hinojosa A, Qin
H.
Solid cancer-directed CAR T
cell
therapy that attacks both tumor and
immunosuppressive cells via targeting PD-L1.
Mol
Ther Oncol. 2024 Oct 5;32(4):200891. doi:
10.1016/j.omton.2024.200891. PMID:
39498357. Laboratory investigation. ˍ
Chida D, Okita Y, Utsugi R, Kuroda H, Hirayama R, Kijima N,
Arisawa A, Kagawa N, Kanemura Y, Yoshimura S, Tomiyama N, Kishima
H.
Dynamic susceptibility
contrast‑enhanced perfusion magnetic resonance imaging
parameters for predicting MGMT
promoter methylation and prognostic value in newly diagnosed
patients with glioblastoma.
Oncol
Lett. 2024 Oct 14;28(6):610. doi:
10.3892/ol.2024.14741. PMID:
39493435. Observational study. ˍ
Dwianingsih EK, Pranacipta S, Theresia E, Safitri S, Hartanto RA,
Malueka RG.
The role of the Ki-67
labelling index as an independent prognostic factor in indonesian
glioma patients.
Histol
Histopathol. 2024 Oct 15:18833. doi:
10.14670/HH-18-833. PMID:
39497648. Observational study. ˍ
Kim S, Jung BK, Kim J, Jeon JH, Kim M, Jang SH, Kim CS, Jang H.
Anticancer
effect of the oncolytic Newcastle
disease virus harboring the PTEN gene on
glioblastoma.
Oncol
Lett. 2024 Oct 16;29(1):6. doi:
10.3892/ol.2024.14752. PMID:
39492938. Laboratory investigation. ˍ
Cai Z, Yang Z, Wang Y, Li Y, Zhao H, Zhao H, Yang X, Wang C, Meng
T, Tong X, Zheng H, He Z, Niu C, Yang J, Chen F, Yang Z, Zou Z, Li
W.
Tumor treating induced fields: a
new treatment option for patients with glioblastoma.
Front
Neurol. 2024 Oct 17;15:1413236. doi:
10.3389/fneur.2024.1413236. PMID:
39484048. Laboratory investigation. ˍ